Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia

被引：0
|
作者：
Inomata, Minoru [1 ]
Miura, Yukiko [1 ]
Kokuho, Nariaki [1 ]
Hayashi, Hiroki [1 ]
Nei, Takahito [1 ]
Kamio, Koichiro [1 ]
Fujita, Kazue [1 ]
Saito, Yoshinobu [1 ]
Gemma, Akihiko [1 ]
Saito, Takefumi [2 ]
Azuma, Arata [1 ]
机构：
[1] Grad Sch Med, Nippon Med Sch, Dept Pulm Med & Oncol, Tokyo, Japan
[2] Ibaraki Higashi Natl Hosp, Dept Resp Med, Ibaraki, Japan
来源：
EUROPEAN RESPIRATORY JOURNAL | 2015年 / 46卷
关键词：
Idiopathic pulmonary fibrosis; Interstitial lung disease; Interstitial lung disease (connective tissue disease);
D O I：
10.1183/13993003.congress-2015.OA4497
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA4497
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The clinical experience of pirfenidone based on corticosteroids and immunosuppressant treatment for interstitial pneumonia with autoimmune features
    黄慧
    China Medical Abstracts(Internal Medicine), 2019, 36 (04) : 216 - 216
  • [22] The Role of Pirfenidone in the Treatment of Interstitial Pneumonia with Autoimmune Features
    Weng, D.
    Chen, T.
    Li, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [23] The role of pirfenidone in the treatment of interstitial pneumonia with autoimmune features
    Chen, T.
    Li, Q-H
    Zhang, Y.
    Yin, C-S
    Weng, D.
    Zhou, Y.
    Hu, Y.
    Shi, J-Y
    Chen, Y-N
    Ye, S.
    Wang, X-D
    Wu, C-Y
    Huang, Y.
    Zhang, A-H
    Li, H-P
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (03) : 560 - 567
  • [24] Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia
    Nishiyama, Osamu
    Yamazaki, Ryo
    Saeki, Sho
    Sano, Hiroyuki
    Iwanaga, Takashi
    Higashimoto, Yuji
    Kume, Hiroaki
    Tohda, Yuji
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [25] A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis
    Daniil, ZD
    Gilchrist, FC
    Nicholson, AG
    Hansell, DM
    Harris, J
    Colby, TV
    du Bois, RM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (03) : 899 - 905
  • [26] Cicatricial organising pneumonia associated with fibrosing interstitial pneumonia - a clinicopathological study
    Zaizen, Yoshiaki
    Tabata, Kazuhiro
    Yamano, Yasuhiko
    Takei, Reoto
    Kataoka, Kensuke
    Shiraki, Akira
    Nishimura, Koichi
    Furuyama, Kazuto
    Bychkov, Andrey
    Hoshino, Tomoaki
    Johkoh, Takeshi
    Kondoh, Yasuhiro
    Fukuoka, Junya
    HISTOPATHOLOGY, 2022, 80 (02) : 279 - 290
  • [27] Efficacy of Antifibrotic Treatments in Patients with Progressive Fibrosing Interstitial Lung Disease
    Sugino, K.
    Ono, H.
    Saito, M.
    Ando, M.
    Tsuboi, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [28] CLINICAL EFFICACY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Yamauchi, H.
    Bando, M.
    Sata, M.
    Nakasone, E.
    Mizushina, Y.
    Suzuki, E.
    Mato, N.
    Nakaya, T.
    Yamasawa, H.
    Sugiyama, Y.
    RESPIROLOGY, 2011, 16 : 318 - 319
  • [29] Idiopathic nonspecific interstitial pneumonia: Prognostic significance of cellular and fibrosing patterns - Survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia
    Travis, WD
    Matsui, K
    Moss, J
    Ferrans, VJ
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (01) : 19 - 33
  • [30] A cohort study of mortality predictors in patients with acute exacerbation of chronic fibrosing interstitial pneumonia
    Usui, Yutaka
    Kaga, Akiko
    Sakai, Fumikazu
    Shiono, Ayako
    Komiyama, Ken-ichiro
    Hagiwara, Koichi
    Kanazawa, Minoru
    BMJ OPEN, 2013, 3 (07):
12345